SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-22-029836
Filing Date
2022-11-14
Accepted
2022-11-14 16:15:13
Documents
55
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vyne-20220930.htm   iXBRL 10-Q 1050337
2 EX-3.1(B) vyne-31bcertificateofdesig.htm EX-3.1(B) 143630
3 EX-3.2 vyne-32arbylaws.htm EX-3.2 194465
4 EX-10.1 vyne-101spa.htm EX-10.1 236478
5 EX-10.2 vyne-102rra.htm EX-10.2 150892
6 EX-31.1 vyne-20220930xexx311.htm EX-31.1 9711
7 EX-31.2 vyne-20220930xexx312.htm EX-31.2 9705
8 EX-32.1 vyne-20220930xexx321.htm EX-32.1 5289
9 EX-32.2 vyne-20220930xexx322.htm EX-32.2 5280
  Complete submission text file 0001628280-22-029836.txt   5656944

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vyne-20220930.xsd EX-101.SCH 31740
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vyne-20220930_cal.xml EX-101.CAL 53481
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vyne-20220930_def.xml EX-101.DEF 207718
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vyne-20220930_lab.xml EX-101.LAB 438994
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vyne-20220930_pre.xml EX-101.PRE 293040
49 EXTRACTED XBRL INSTANCE DOCUMENT vyne-20220930_htm.xml XML 656017
Mailing Address 685 ROUTE 202/206, SUITE 301A BRIDGEWATER NJ 08807
Business Address 685 ROUTE 202/206, SUITE 301A BRIDGEWATER NJ 08807 800-775-7936
VYNE Therapeutics Inc. (Filer) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38356 | Film No.: 221385538
SIC: 2834 Pharmaceutical Preparations